These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8587511)
21. Large-scale purification of the F1 antigen of Yersinia pestis. Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865 [No Abstract] [Full Text] [Related]
22. A therapeutic strategy against the shared virulence mechanism utilized by both Yersinia pestis and Pseudomonas aeruginosa. Sawa T; Wiener-Kronish JP Anesthesiol Clin North Am; 2004 Sep; 22(3):591-606, viii-ix. PubMed ID: 15325721 [TBL] [Abstract][Full Text] [Related]
23. The action of the Yersinia pestis phage on the plague envelope antigen and the human erythrocytes. Kunikowska D; Głośnicka R Bull Inst Marit Trop Med Gdynia; 1985; 36(1-4):103-15. PubMed ID: 3841818 [TBL] [Abstract][Full Text] [Related]
24. [Changes in the biological properties of Yersinia pestis during long-term intracellular multiplication]. Vasil'eva GI; Doroshenko EP; Kiseleva AK Mikrobiol Zh (1978); 1988; 50(2):30-3. PubMed ID: 3249571 [No Abstract] [Full Text] [Related]
26. [The aggregation ability of the plague microbe]. Briukhanova GD; Akiev AK; Beĭer AP Med Parazitol (Mosk); 1995; (4):10-4. PubMed ID: 8587509 [TBL] [Abstract][Full Text] [Related]
27. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses. Elvin SJ; Williamson ED Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741 [No Abstract] [Full Text] [Related]
28. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge. Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482 [TBL] [Abstract][Full Text] [Related]
29. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474 [TBL] [Abstract][Full Text] [Related]
30. Identification and type III-dependent secretion of the Yersinia pestis insecticidal-like proteins. Gendlina I; Held KG; Bartra SS; Gallis BM; Doneanu CE; Goodlett DR; Plano GV; Collins CM Mol Microbiol; 2007 Jun; 64(5):1214-27. PubMed ID: 17542916 [TBL] [Abstract][Full Text] [Related]
31. The yersiniae--a model genus to study the rapid evolution of bacterial pathogens. Wren BW Nat Rev Microbiol; 2003 Oct; 1(1):55-64. PubMed ID: 15040180 [TBL] [Abstract][Full Text] [Related]
32. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052 [TBL] [Abstract][Full Text] [Related]
33. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains. Sabhnani L; Manocha M; Tomar D; Shashikiran D; Rao DN Int Immunopharmacol; 2003 Oct; 3(10-11):1413-8. PubMed ID: 12946437 [TBL] [Abstract][Full Text] [Related]
34. Yersinia pestis: still a plague in the 21st century. Josko D Clin Lab Sci; 2004; 17(1):25-9. PubMed ID: 15011977 [TBL] [Abstract][Full Text] [Related]
35. [Immunologic activity of the "murine" toxin of the plague microbe in experiments on animals]. Evstigneev VI; Chicherin IuV; Byvalov AA; Pautov VN; Dodonov NP Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):39-42. PubMed ID: 7245966 [No Abstract] [Full Text] [Related]
36. [Results of verifying the hypothesis of the constant passage of the plague causative agent on a mathematical model]. Rudenchik IuV; Soldatkin IS Med Parazitol (Mosk); 1976; 45(3):284-9. PubMed ID: 781502 [No Abstract] [Full Text] [Related]
37. [Dependence of block formation in fleas on the characteristics of the carbohydrate metabolism in the plague microbe]. Kozlov MP; Rozanova GN Parazitologiia; 1974; 8(3):254-60. PubMed ID: 4836620 [No Abstract] [Full Text] [Related]
38. [Heterogenetic antigens of plague and cholera microbes, similar to antigens of human and animal tissues]. Zhukov-Berezhnilov NN; Adamov AK; Anisimov PI; Bochko GM; Podoplelov II Biull Eksp Biol Med; 1972 Apr; 73(4):63-5. PubMed ID: 4623967 [No Abstract] [Full Text] [Related]